3919 V (Levothyroxine 125 mcg (0.125 mg))
Pill imprint 3919 V has been identified as Levothyroxine sodium 125 mcg (0.125 mg).
Levothyroxine is used in the treatment of hashimoto's disease; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test; underactive thyroid (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 125 mcg (0.125 mg) is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 3919 V
- Strength:
- 125 mcg (0.125 mg)
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Thyroid drugs
- Pregnancy Category:
- A - Studies show no risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- United Research Laboratories/Mutual Pharmaceutical Company
More about levothyroxine
Consumer resources
- Levothyroxine
- Levothyroxine capsules
- Levothyroxine solution
- Levothyroxine (Advanced Reading)
- Levothyroxine Injection (Advanced Reading)
- Other brands: Synthroid, Levoxyl, Tirosint, Levothroid, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
